MEN1 syndrome: an anusual case

MEN1 syndrome: an anusual case

Authors

  • Elena Guidetti Dipartimento di Medicina Clinica. Università degli Studi di Bologna, Ospedale Policlinico S. Orsola Malpighi, via Massarenti 9, 40138, Bologna, Italia

  • Monica Cevenini Dipartimento di Medicina Clinica. Università degli Studi di Bologna, Ospedale Policlinico S. Orsola Malpighi, via Massarenti 9, 40138, Bologna, Italia

  • Maria Luigia Cipollini Dipartimento di Medicina Clinica. Università degli Studi di Bologna, Ospedale Policlinico S. Orsola Malpighi, via Massarenti 9, 40138, Bologna, Italia

  • Martina Ferrata Dipartimento di Medicina Clinica. Università degli Studi di Bologna, Ospedale Policlinico S. Orsola Malpighi, via Massarenti 9, 40138, Bologna, Italia

  • Paola Tomassetti Dipartimento di Medicina Clinica. Università degli Studi di Bologna, Ospedale Policlinico S. Orsola Malpighi, via Massarenti 9, 40138, Bologna, Italia

  • Roberto Corinaldesi Dipartimento di Medicina Clinica. Università degli Studi di Bologna, Ospedale Policlinico S. Orsola Malpighi, via Massarenti 9, 40138, Bologna, Italia



DOI:

https://doi.org/10.7175/cmi.v6i1S.493

Keywords:

Multiple endocrine neoplasia type 1, MEN1 Gene, Genetic testing, Gastrinoma, Pancreatic neuroendocrine tumors

Abstract

Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal dominant endocrine disorder and is characterised by the concurrent appearance of adenomas of the parathyroid glands, neuroendocrine-enteropancreatic tumours, and pituitary adenomas, as well as other types of less frequent tumours, such as adrenal cortical tumours, carcinoid tumours, lipomas, etc. Two different forms, familial and sporadic, have been described. The gene responsible, MEN1, consists of 10 exons encoding a 610-amino acid protein known as menin. The MEN1 syndrome is caused by inactivating mutations in MEN1 tumour suppressor gene. The combination of clinical and genetic investigation helps in the diagnosis. Genetic testing has been advocated to identify MEN1 carriers of the MEN1 families for the purpose of earlier detection of tumours. We present a patient with traditionally described manifestations of MEN1 (a parathyroid hyperplasia associated with a pancreatic neuroendocrine tumour and a gastrinoma), but with a negative genetic test for the MEN1 mutation.

Downloads

Published

2015-10-13

Issue

Section

Case report
Loading...